Skip to main

Submitted outputs' details

The submitted outputs' details allows you to browse and search for outputs submitted to the REF 2021. Use the search and filters below to find the outputs you are looking for.
Learn about submitted outputs
Download all details for all outputs (spreadsheet)
Download all details for all outputs (spreadsheet) (generating)

Search and filter

Clear search and filter

Filter by

  • Institute of Cancer Research: Royal Cancer Hospital (The)
   None selected
  • 1 - Clinical Medicine
   None selected
   None selected
   None selected
   None selected
Download output details for outputs in the current view (spreadsheet)
Download output details for outputs in the current view (spreadsheet) (generating)
Showing outputs 1 to 100 of 176

89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1158/1078-0432.CCR-14-0491
Open access status
Out of scope for open access requirements
Title of journal
Clin Cancer Res

8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1021/acs.jmedchem.5b01635
Open access status
Out of scope for open access requirements
Title of journal
J Med Chem

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1016/j.cell.2016.08.041
Open access status
Compliant
Title of journal
Cell

A comprehensive model for heat-induced radio-sensitisation.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1080/02656736.2017.1341059
Open access status
Compliant
Title of journal
Int J Hyperthermia

A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1158/2159-8290.CD-15-0068
Open access status
Out of scope for open access requirements
Title of journal
Cancer Discov

A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1016/j.molcel.2015.07.009
Open access status
Out of scope for open access requirements
Title of journal
Mol Cell

A genome-wide association study identifies multiple susceptibility loci for chronic ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1038/ng.2843
Open access status
Out of scope for open access requirements
Title of journal
Nat Genet

A kinase-independent function of AKT promotes cancer cell survival.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.7554/eLife.03751
Open access status
Out of scope for open access requirements
Title of journal
Elife

A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1158/1078-0432.CCR-17-2260
Open access status
Compliant
Title of journal
Clin Cancer Res

A selective chemical probe for exploring the role of CDK8 and CDK19 in human dis ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1038/nchembio.1952
Open access status
Out of scope for open access requirements
Title of journal
Nat Chem Biol

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1056/NEJMoa1702900
Open access status
Compliant
Title of journal
N Engl J Med

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1016/S1470-2045(17)30404-7
Open access status
Compliant
Title of journal
Lancet Oncol

Activity of cabazitaxel in castration-resistant prostate cancer progressing after ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1016/j.eururo.2013.11.044
Open access status
Out of scope for open access requirements
Title of journal
Eur Urol

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1093/annonc/mdy072
Open access status
Compliant
Title of journal
Ann Oncol

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1093/annonc/mdz396
Open access status
Compliant
Title of journal
Ann Oncol

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1016/S0140-6736(15)01037-5
Open access status
Out of scope for open access requirements
Title of journal
Lancet

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/S0140-6736(20)30415-3
Open access status
Compliant
Title of journal
Lancet

Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/j.omto.2020.07.005
Open access status
Compliant
Title of journal
Mol Ther Oncolytics

Analysis of 153 115 patients with hematological malignancies refines the spectrum ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1182/blood.2019001362
Open access status
Compliant
Title of journal
Blood

Androgen receptor splice variant-7 expression emerges with castration resistance ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1172/JCI122819
Open access status
Compliant
Title of journal
J Clin Invest

Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1073/pnas.1714089115
Open access status
Compliant
Title of journal
Proc Natl Acad Sci U S A

APC/C is an essential regulator of centrosome clustering.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1038/ncomms4686
Open access status
Out of scope for open access requirements
Title of journal
Nat Commun

Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1073/pnas.1315798111
Open access status
Out of scope for open access requirements
Title of journal
Proc Natl Acad Sci U S A

Assessing the mechanism and therapeutic potential of modulators of the human Mediator ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.7554/eLife.20722
Open access status
Compliant
Title of journal
Elife

Assessment of treatment response by total tumor volume and global apparent diffusion ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1371/journal.pone.0091779
Open access status
Out of scope for open access requirements
Title of journal
PLoS One

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1038/s41588-018-0142-8
Open access status
Exception within 3 months of publication
Title of journal
Nat Genet

Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1001/jamaoncol.2018.1771
Open access status
Compliant
Title of journal
JAMA Oncol

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenviron ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1158/1078-0432.CCR-18-1821
Open access status
Compliant
Title of journal
Clin Cancer Res

ATR Is a Therapeutic Target in Synovial Sarcoma.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1158/0008-5472.CAN-17-2056
Open access status
Compliant
Title of journal
Cancer Res

Bicyclic inhibitors of PAD4

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
F - Patent/ published patent application
Year
2017

Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1021/acs.jmedchem.8b01721
Open access status
Compliant
Title of journal
J Med Chem

Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.7326/M18-1323
Open access status
Compliant
Title of journal
Ann Intern Med

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1056/NEJMoa1911206
Open access status
Not compliant
Title of journal
N Engl J Med

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1200/JCO.19.00368
Open access status
Compliant
Title of journal
J Clin Oncol

Capture Hi-C identifies putative target genes at 33 breast cancer risk loci.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1038/s41467-018-03411-9
Open access status
Compliant
Title of journal
Nat Commun

Capture Hi-C identifies the chromatin interactome of colorectal cancer risk loci ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1038/ncomms7178
Open access status
Out of scope for open access requirements
Title of journal
Nat Commun

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1038/s41591-018-0009-7
Open access status
Compliant
Title of journal
Nat Med

CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1158/2326-6066.CIR-19-0449
Open access status
Deposit exception
Title of journal
Cancer Immunol Res

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1016/S1470-2045(19)30215-3
Open access status
Compliant
Title of journal
Lancet Oncol

Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1038/bjc.2017.75
Open access status
Compliant
Title of journal
Br J Cancer

Characterizing CDK12-Mutated Prostate Cancers.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1158/1078-0432.CCR-20-2371
Open access status
Compliant
Title of journal
Clin Cancer Res

CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1158/0008-5472.CAN-19-1372
Open access status
Compliant
Title of journal
Cancer Res

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/S1470-2045(20)30444-7
Open access status
Compliant
Title of journal
Lancet Oncol

Clinical and patient-reported outcomes of SPARE - a randomised feasibility study ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1111/bju.13900
Open access status
Compliant
Title of journal
BJU Int

Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1016/j.ijrobp.2017.01.239
Open access status
Compliant
Title of journal
Int J Radiat Oncol Biol Phys

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1016/j.eururo.2019.04.006
Open access status
Compliant
Title of journal
Eur Urol

Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1182/blood-2014-07-584268
Open access status
Out of scope for open access requirements
Title of journal
Blood

Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pa ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/j.annonc.2020.05.009
Open access status
Compliant
Title of journal
Annals of Oncology

Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1200/JCO.18.00889
Open access status
Compliant
Title of journal
J Clin Oncol

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1093/neuonc/nov173
Open access status
Out of scope for open access requirements
Title of journal
Neuro Oncol

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1016/j.ccell.2014.11.002
Open access status
Out of scope for open access requirements
Title of journal
Cancer Cell

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1016/S1470-2045(16)30102-4
Open access status
Compliant
Title of journal
Lancet Oncol

Copy number evolution and its relationship with patient outcome-an analysis of 178 ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1038/s41375-020-01096-y
Open access status
Compliant
Title of journal
Leukemia

Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1016/j.jtho.2018.09.025
Open access status
Compliant
Title of journal
J Thorac Oncol

CXCL10-induced migration of adoptively transferred human natural killer cells toward ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1007/s00262-014-1629-5
Open access status
Out of scope for open access requirements
Title of journal
Cancer Immunol Immunother

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1634/theoncologist.2014-0372
Open access status
Out of scope for open access requirements
Title of journal
Oncologist

Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1021/acs.jmedchem.7b01406
Open access status
Compliant
Title of journal
J Med Chem

Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1016/j.celrep.2015.02.059
Open access status
Out of scope for open access requirements
Title of journal
Cell Rep

Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1021/acs.jmedchem.5b01685
Open access status
Out of scope for open access requirements
Title of journal
J Med Chem

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1056/NEJMoa1506859
Open access status
Out of scope for open access requirements
Title of journal
N Engl J Med

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1016/S1470-2045(14)70063-4
Open access status
Out of scope for open access requirements
Title of journal
Lancet Oncol

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1016/j.celrep.2016.10.005
Open access status
Compliant
Title of journal
Cell Rep

Dynamic tumor tracking using the Elekta Agility MLC.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1118/1.4899175
Open access status
Out of scope for open access requirements
Title of journal
Med Phys

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/S1470-2045(20)30392-2
Open access status
Compliant
Title of journal
Lancet Oncol

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1200/JCO.2015.65.7692
Open access status
Compliant
Title of journal
J Clin Oncol

Effect of sleep deprivation on the human metabolome.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1073/pnas.1402663111
Open access status
Out of scope for open access requirements
Title of journal
Proc Natl Acad Sci U S A

Effects of single-agent and combination chemotherapy for gestational trophoblastic ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1200/JCO.2014.57.5332
Open access status
Out of scope for open access requirements
Title of journal
J Clin Oncol

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1136/gutjnl-2020-322658
Open access status
Compliant
Title of journal
Gut

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1016/S1470-2045(14)70040-3
Open access status
Out of scope for open access requirements
Title of journal
Lancet Oncol

Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1073/pnas.1324136111
Open access status
Out of scope for open access requirements
Title of journal
Proc Natl Acad Sci U S A

Exploring the biomechanical properties of brain malignancies and their pathologic ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1158/0008-5472.CAN-14-1997
Open access status
Out of scope for open access requirements
Title of journal
Cancer Res

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1038/s41467-018-04109-8
Open access status
Compliant
Title of journal
Nat Commun

First evaluation of the feasibility of MLC tracking using ultrasound motion esti ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1118/1.4955440
Open access status
Compliant
Title of journal
Med Phys

First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1158/1078-0432.CCR-14-0947
Open access status
Out of scope for open access requirements
Title of journal
Clin Cancer Res

Functional diversity and cooperativity between subclonal populations of pediatric ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1038/s41591-018-0086-7
Open access status
Compliant
Title of journal
Nat Med

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1136/gutjnl-2017-314178
Open access status
Compliant
Title of journal
Gut

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1200/JCO.2014.56.5689
Open access status
Out of scope for open access requirements
Title of journal
J Clin Oncol

Genome-wide association study of glioma subtypes identifies specific differences ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1038/ng.3823
Open access status
Compliant
Title of journal
Nat Genet

Germ line mutations in shelterin complex genes are associated with familial chronic ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1182/blood-2016-01-695692
Open access status
Compliant
Title of journal
Blood

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1016/j.eururo.2019.01.050
Open access status
Compliant
Title of journal
Eur Urol

Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1093/annonc/mdz136
Open access status
Compliant
Title of journal
Ann Oncol

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1158/2159-8290.CD-15-1246
Open access status
Compliant
Title of journal
Cancer Discov

Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1016/S1470-2045(15)00461-1
Open access status
Out of scope for open access requirements
Title of journal
Lancet Oncol

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/S0140-6736(20)30932-6
Open access status
Compliant
Title of journal
Lancet

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2015
DOI
10.1016/S1470-2045(15)00280-6
Open access status
Out of scope for open access requirements
Title of journal
Lancet Oncol

Identification of 19 new risk loci and potential regulatory mechanisms influencing ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1038/ng.3896
Open access status
Compliant
Title of journal
Nat Genet

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1038/s41467-018-04989-w
Open access status
Compliant
Title of journal
Nat Commun

IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2018
DOI
10.1002/path.5008
Open access status
Compliant
Title of journal
J Pathol

Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1136/gutjnl-2020-321016
Open access status
Compliant
Title of journal
Gut

Immunomodulatory activity of IR700-labelled affibody targeting HER2.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1038/s41419-020-03077-6
Open access status
Compliant
Title of journal
Cell Death Dis

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1158/2159-8290.CD-19-1030
Open access status
Compliant
Title of journal
Cancer Discov

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2016
DOI
10.1056/NEJMoa1603144
Open access status
Compliant
Title of journal
N Engl J Med

Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2017
DOI
10.1016/j.ccell.2017.08.017
Open access status
Compliant
Title of journal
Cancer Cell

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1016/S1470-2045(19)30569-8
Open access status
Compliant
Title of journal
Lancet Oncol

Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1002/path.5224
Open access status
Compliant
Title of journal
J Pathol

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2019
DOI
10.1016/j.eururo.2019.08.019
Open access status
Compliant
Title of journal
Eur Urol

Intermittent schedules of the oral RAF-MEK inhibitor CH5126766/VS-6766 in patients ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/S1470-2045(20)30464-2
Open access status
Compliant
Title of journal
Lancet Oncol

Intraclonal heterogeneity is a critical early event in the development of myeloma ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2014
DOI
10.1038/leu.2013.199
Open access status
Out of scope for open access requirements
Title of journal
Leukemia

Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1016/j.ijrobp.2020.06.022
Open access status
Compliant
Title of journal
Int J Radiat Oncol Biol Phys

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and ...

Submitting institution
Institute of Cancer Research: Royal Cancer Hospital (The)
Unit of assessment
1 - Clinical Medicine
Type
D - Journal article
Year of publication
2020
DOI
10.1200/PO.20.00050
Open access status
Compliant
Title of journal
JCO Precis Oncol
Showing outputs 1 to 100 of 176

Filter by higher education institution

Select one or more of the following higher education institutions and then click Apply selected filters when you have finished.
No higher education institutions found.

Filter by unit of assessment

Select one or more of the following units of assessment and then click Apply selected filters when you have finished.
No unit of assessments found.

Filter by output type

Select one or more of the following output types and then click Apply selected filters when you have finished.

Filter by year

Select one or more of the following years and then click Apply selected filters when you have finished.

Filter by open access status

Select one or more of the following open access statuses and then click Apply selected filters when you have finished.